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As described elsewhere in this mini-
monograph, the first systematic attempt to
develop a structured approach to assessment
of the allergenic potential of novel food
proteins was sponsored jointly by the
International Food Biotechnology Council
(IFBC) and the International Life Sciences
Institute (ILSI) Allergy and Immunology
Institute (Metcalfe et al. 1996). The proposed
scheme took the form of a decision tree, the
starting point for which was determined by
the origin of the novel gene and whether or
not it derived from a source considered to be
allergenic. Among the approaches identified
were consideration of the serologic identity of
the novel protein with known human aller-
gens; structural similarity to, or amino acid
sequence homology with, allergenic proteins;
and resistance to proteolytic digestion in a
simulated gastric ﬂuid. Although such investi-
gations provide important information and
are clearly valuable for the identification of
proteins that display serologic or structural
homology with known allergens, they do not
provide a direct assessment of the inherent
sensitizing potential of proteins. For this rea-
son there has been a growing interest in the
design, development, and application of
appropriate animal models. The consensus at
the time of the IFBC/ILSI deliberations was
that no appropriate animal models were avail-
able. Since then, however, progress has been
made, and in 2001 the Food and Agriculture
Organization (FAO) and World Health
Organization (WHO) convened a special con-
sultation panel to consider food allergenicity
testing and possible revisions to the original
IFBC/ILSI decision tree (FAO/WHO 2001).
One of the conclusions (conclusion 10)
reached by the consultation was that 
. . . animal models have not been evaluated for all
food allergens but there is sufﬁcient scientiﬁc evi-
dence that using these models will contribute
valuable information regarding the allergenicity of
foods derived from biotechnology. 
This view has given further impetus to the
development of suitable animal models, and
it is timely now to review what has been
achieved and what has still to be accom-
plished. In this report, progress made in the
design and evaluation of models in the rat,
the mouse, the dog, and in swine is reviewed
and discussed.
Oral and Intraperitoneal
Exposure of Brown Norway
Rats
Animal models to study the sensitizing
potential of new proteins should ideally sat-
isfy several important criteria (Penninks and
Knippels 2001; Taylor and Lehrer 1996) that
are difficult to attain with a single model.
Selection of species and strain, route of expo-
sure for sensitization and challenge as well as
the use of adjuvants are important issues to
consider. One approach is to use the Brown
Norway (BN) strain of rats, as this is a high-
immunoglobulin (particularly IgE) responder
rat strain. Thus, to a certain degree, this BN
rat strain resembles atopic humans in their
genetic predisposition to react more readily to
antigens with production of IgE. It has been
suggested that for the evaluation of intrinsic
allergenic potential of new proteins, oral
application is preferred, and that the presence
of an adjuvant is to be avoided. BN rats have
been used for the study of oral sensitization to
food proteins after administration through
the diet or by gavage dosing either in the
presence (Atkinson et al. 1996) or absence of
an adjuvant (Knippels et al. 1998a, 1998b;
1999a, 1999b; 2000).
Studies by Knippels and colleagues used
ovalbumin (OVA), a well-defined chicken
egg allergen, as a model protein (Knippels et
al. 1998b). In these studies not only the dose
(0.002–20 mg OVA per dose) but also the
mode of application (gavage vs. in the drink-
ing water) and the frequency of application
(daily, twice a week, once a week, once every
2 weeks) were investigated (Knippels et al.
1998b). Daily intragastric administration of
1 mg OVA for 42 consecutive days, without
the use of adjuvants, resulted in the produc-
tion of OVA-specific IgG as well as OVA-
speciﬁc IgE responses in the majority of rats.
In general the percentage of IgE responders to
OVA exceeded 80%, as measured by both
enzyme-linked immunosorbent assay (ELISA)
and homologous passive cutaneous anaphy-
laxis (PCA) assay. Optimal OVA-speciﬁc IgE
antibody responses were observed around
days 28–35. Sometimes, however, no
detectable OVA-specific IgE responses were
induced upon daily gavage dosing with the
same dose (1 mg) of OVA. Generally, using
less-frequent administration regimes of 1 mg
OVA by gavage did not induce specific IgG
or specific IgE antibody responses. Upon
exposure in the drinking water, OVA-speciﬁc
IgG but not OVA-speciﬁc IgE antibody was
produced (Knippels et al. 1998b).
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different strains of rats have been performed
to conﬁrm that the BN strain rat is the most
suitable choice for these experiments
(Knippels et al. 1999b). On the basis of the
results of these studies, it was apparent that
upon oral exposure of Wistar, PVG, hooded
Lister, and BN rats to OVA, only the BN rats
developed OVA-speciﬁc IgE antibodies, con-
ﬁrming that the BN rat was the most suitable
strain for oral sensitization studies.
In subsequent investigations with BN
rats, the sensitizing potential of hen egg white
(HEW) and cow’s milk (CM) proteins was
examined. Although antigen-specific IgG
responses were found upon daily gavage dos-
ing of the animals with different concentra-
tions of HEW or CM, only a limited number
of IgE responders were observed as measured
by PCA. However, immunoblotting experi-
ments with these rat sera demonstrated the
presence of specific IgE antibodies against
both HEW proteins and CM proteins
(Knippels et al. 2000). Moreover, both IgG
and IgE antibodies present in sera of rats sen-
sitized orally to HEW or CM and in sera of
HEW- or CM-allergic patients recognized a
comparable proﬁle of allergens in these food
products. These results indicate that the spe-
ciﬁc protein recognition of induced antibod-
ies in the BN rat is comparable with that
observed in sera from allergic patients
(Knippels et al. 2000).
In addition, BN rats have been sensitized
with different doses of either crude raw peanut
extract or roasted peanut extract. Dose levels
ranged from 0.01 to 10 mg peanut protein
extract per day. No clear differences were
observed in the sensitizing potency of crude
raw peanuts extracts or roasted peanut extracts
as measured by Th (T-helper) 2-mediated
IgG2a production. Although the number of
positive responders increased as the number of
daily exposures increased, the magnitude of
the IgG2a response was similar in the different
dose groups. Only a limited number of ani-
mals were IgE-positive as measured by PCA.
The IgG2a responses of animals sensitized
orally or intraperitoneally with peanut pro-
teins were measured using the three purified
major peanut allergens Ara h1, Ara h2 and Ara
h3 as substrates. After oral sensitization, IgG2a
antibodies were directed against all three
major peanut allergens; however, after
intraperitoneal sensitization, IgG2a antibodies
were directed mainly toward Ara h2.
More recently, the relative allergenicity of
selected allergenic and nonallergenic proteins,
based on human experience, has been investi-
gated in the BN rat oral exposure model. In
these studies Ara h1 purified from peanut,
tropomyosin purified from shrimp or beef,
and patatin puriﬁed from potatoes were eval-
uated. Preliminary results indicated marked
differences in the two identical sensitization
studies performed with these puriﬁed proteins
in BN rats. Investigators found that the rats
in the ﬁrst study had been unexpectedly pre-
exposed in the diet to one allergen used for
sensitization and to a cross-reacting allergen,
and it is assumed that this affected the results.
In the second study the oral sensitizing poten-
tial decreased in the following order: Ara h1 >
shrimp tropomyosin > patatin, with no sensi-
tization to beef tropomyosin in both studies.
In previous oral sensitization studies with
soy proteins, it has been shown that unsched-
uled dietary preexposure of test animals, or
their parental generation, to the antigen
under investigation has important inﬂuences
on the results of oral sensitization studies
(Knippels et al. 1998a). Exposure of the
parental generation to soy was found to inﬂu-
ence the outcome of sensitization studies with
the offspring. These studies showed that BN
rats bred and raised on a soy protein–contain-
ing diet for several generations have soy-
speciﬁc IgG antibodies. When these rats were
fed before breeding with a soy protein–free
diet for 6 months, soy protein–specific IgG
antibodies were still detectable in the parental
animals and also in serum samples collected
from the F1 generation of offspring rats fed
on soy protein–free diets for periods up to
6–12 months. In the second, third, and
fourth generations of offspring bred on a soy
protein–free diet, no soy-specific IgG was
detected. Oral sensitization to soy could be
achieved in these rats. Therefore, when oral
sensitization studies with proteins are per-
formed, at least two generations of animals
have to be bred on a diet free of the antigen
under investigation to get immunologically
naïve and therefore responsive animals. 
The BN rat food allergy model was
characterized further by Knippels et al.
(1999a), who studied immune-mediated
effects upon oral challenge of sensitized ani-
mals. Local effects induced by oral challenge
were studied by measuring gut permeability.
Upon an oral challenge with OVA in OVA-
sensitized BN rats, gut permeability was
increased, as evidenced by an increased
uptake of a bystander protein (β-lactoglobu-
lin). In addition to studies on local effects,
systemic effects were investigated by monitor-
ing respiratory functions and blood pressure
changes (Knippels et al. 1999a). Under the
test conditions used, oral challenge with OVA
induced only minor effects on the respiratory
system or blood pressure in a minority of ani-
mals. However, this low incidence is consid-
ered to be in accordance with clinical
observations in food-allergic patients.
In conclusion the results obtained to date
indicate that the BN rat might be a useful
animal model in which to study the potential
oral allergenicity of novel food proteins
(Knippels and Penninks 2003). However,
further testing with either whole food or with
additional purified non-, weak-, and strong-
allergenic proteins is needed for a more in-
depth evaluation of this BN rat model.
Moreover, the BN rat model may also be a
promising tool to study in more detail various
mechanistic aspects of food allergy, which
might result in new opportunities with
respect to prophylaxis and therapy. 
Oral and Systemic Exposure 
of BALB/c Mice
The Balb/c mouse has also been utilized to
evaluate the sensitizing potential of novel pro-
teins. An advantage of this model is that the
Balb/c mouse strain is known to favor the
development of Th2 type immune responses
and the production of IgE antibody. 
Although it has been argued that, in the
context of assessing the safety of dietary pro-
teins, oral administration is the preferred route
of exposure, it has been demonstrated that such
a regimen may lack the sensitivity required for
effective identiﬁcation of inherent sensitizing
potential. This is probably attributable, at least
in part, to the fact that oral exposure may be
associated with the development of tolerance
(Strobel and Mowat 1998). Consequently, the
studies described below focus primarily on
systemic (usually intraperitoneal) exposure of
mice to the protein of interest. 
Using the Balb/c mouse, it is possible to
measure the quality and vigor of immune
responses after systemic exposure to proteins
and to deﬁne these proteins as having inherent
sensitizing potential if they provoke clear IgE
antibody responses. In effect the strategy is to
distinguish between immunogenic proteins
(that are able to induce speciﬁc IgG antibody
responses, but not IgE responses) and poten-
tially allergenic proteins (that are able under
these conditions to provoke both IgG and IgE
antibody production). It has been possible
using this approach to demonstrate clear differ-
ences between proteins with respect to IgE
antibody production. Thus, under conditions
of exposure where different proteins elicit
largely comparable IgG antibody responses,
there can be very substantial variations in their
ability to induce specific IgE antibody
(Dearman et al. 2000, 2001; Dearman and
Kimber 2001; Hilton et al. 1994, 1997). It is
assumed that such differences are predicated
on the characteristics of the protein that in
turn inﬂuence the nature of induced immune
responses. Among the features that may be
important in this respect are the following: size,
proteolytic stability, biological function
(including enzymatic activity), glycosylation
status, overall immunogenicity and the ways in
which protein is processed for subsequent pre-
sentation to the immune system (Huby et al.
2000; Kimber and Dearman 2001a).
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approach is designed speciﬁcally to serve as a
tool for hazard identiﬁcation and characteriza-
tion (Dearman and Kimber 2001; Kimber et
al. 2000; Kimber and Dearman 2001b). It
must be acknowledged that proteins deﬁned as
having an inherent sensitizing potential as a
function of their ability to stimulate IgE
responses may not necessarily represent a risk
for human health. For instance, a protein with
inherent allergenic activity as defined above
may fail in humans to cause sensitization when
experienced in the diet or if levels of exposure
are insufﬁcient to elicit an immune response.
Clearly, development of risk assessments for
human allergic disease is going to be problem-
atic (not least because of the congenital and
acquired factors that inﬂuence interindividual
differences in susceptibility), but any effective
safety assessment process must incorporate a
sensitive and selective method for identifying
potential hazards. It is our view that this
approach employing BALB/c strain mice is
currently the best way forward. 
The standard protocol used by Kimber
and colleagues (Dearman et al. 2001, 2002)
can be summarized brieﬂy as follows. Groups
of mice (conventionally five per group)
receive one of various concentrations of the
test protein by intraperitoneal injection.
Seven days later this treatment is repeated. At
various periods following the initiation of
exposure, mice are exsanguinated by cardiac
puncture. Individual and pooled serum sam-
ples are prepared and stored frozen until
analysis. Protein-specific IgG antibody
responses are measured using ELISA. For the
evaluation of IgE antibody responses, a
homologous PCA assay is used. Studies using
three proteins of differing sensitizing potential
serve to provide an illustrative example of
results obtained with this protocol.
Mice were exposed to equal volumes of
either 0.2% peanut agglutinin (a minor aller-
gen of the peanut) (Barnett et al. 1983; Burks
et al. 1994), 2% ovalbumin (OVA), or a crude
potato protein extract (PPE; 10%) containing
acid phosphatase activity (and which is
assumed to lack signiﬁcant sensitizing activity).
All proteins elicited specific IgG antibody
responses that were of maximal vigor 14 days
after the initiation of exposure. Under these
same conditions of exposure, strong IgE
responses were observed 14, 28, and 42 days
after exposure of mice to either peanut agglu-
tinin or OVA. In contrast, PPE failed to stim-
ulate high-titer IgE antibody, with only a very
weak and transient signal detectable at 28 days.
In separate experiments, responses induced
in mice after intraperitoneal administration
have been compared with those observed after
gavage exposure. In the latter case mice
received a daily gavage dose of 1 mg test
protein for 28 or 42 days. Results obtained
with OVA are instructive. Although oral dos-
ing resulted in the elicitation of IgG antibody
responses in a proportion of exposed mice,
only variable and low-grade IgE antibody pro-
duction was found. This is in contrast to the
strong IgE responses observed after systemic
exposure of mice to OVA (Dearman et al.
2001). As discussed above, the difficulty in
generating robust IgE responses to OVA sug-
gests that for the purposes of hazard identiﬁca-
tion and assessment of inherent sensitizing
activity, systemic exposure may be more
appropriate than oral dosing.
Against this background the need now is
for a more extensive and more searching eval-
uation of the accuracy and utility of this
approach, and to this end it will be necessary
to examine the characteristics of antibody
responses induced by a wider range of proteins
(including known allergens and proteins
known or believed not to cause allergic sensiti-
zation). It will be necessary also to determine
the reliability and robustness of the method
within the context of well-managed interlabo-
ratory collaborative trials. In addition to fur-
ther examination of this experimental
approach for the purposes of hazard identiﬁca-
tion and characterization, other research
objectives are currently being addressed. 
The ﬁrst of these relates to the inﬂuence of
resistance to proteolytic digestion on sensitiz-
ing activity. Previous investigations have indi-
cated that there exists an association between
the resistance of proteins to digestion in a sim-
ulated gastric fluid and sensitizing activity
(Astwood et al. 1996). Although this correla-
tion is not absolute, evaluation of resistance to
proteolysis is currently regarded as one compo-
nent of the safety assessment process (Bannon
et al. 2003). It is frequently assumed that such
an association reﬂects the fact that for a protein
to induce sensitization after oral ingestion, it
will have to display some level of stability in
the gastric environment in order to interact
effectively with the mucosal immune system.
However, it is clear (after gavage exposure at
least) that even unstable proteins are able to
elicit immune responses in mice when dosed
orally (Dearman et al. 2002). On this basis it
seems reasonable to suggest that the observed
correlation with resistance to proteolysis may
not be attributable solely to survivability in
the gastrointestinal tract. One hypothesis is
that the susceptibility or otherwise to prote-
olytic digestion may impact on the way in
which antigen-presenting cells process pro-
teins for subsequent presentation to the
immune system.
A second objective would be to
characterize in greater detail the quality of
immune responses provoked in mice by
protein immunogens and protein allergens.
Investigations are focused currently on deﬁni-
tion of the cytokine secretion proﬁles induced
by proteins. Preliminary evidence indicates
that, as expected, and consistent with their
ability to elicit IgE antibody responses, pro-
teins with known sensitizing potential are
associated with a preferential type 2 cytokine
expression phenotype. It remains to be seen
whether evaluation of cytokine secretion pro-
files provides an additional or alternative
approach to the identification of inherent
sensitizing activity.
Assessment of Allergenicity 
in Dogs I
Thioredoxin reduces disulfide (S–S) groups
on proteins to the sulfhydryl state, and
researchers have examined whether thiore-
doxin-induced changes in disulfide proteins
affect the recognition of these proteins by IgE
antibody. To address this question, studies
have been performed using high IgE–produc-
ing dogs (Ermel et al. 1997). These animals
were descended from a colony of inbred, high
IgE–producing spaniel/retriever/basenji
dogs maintained at the Animal Resources
Service, School of Veterinary Medicine at the
University of California, Davis (Davis,
California, USA).
On the basis of skin-test challenge of dogs
sensitized previously to the native proteins,
the disulﬁde allergens that have been studied
show decreased allergenicity upon reduction
by thioredoxin, apparently as a result of
changes in IgE epitope accessibility. This
decrease was demonstrated first with the
major allergens of wheat [this decrease was
shown with gliadins and glutenins in dogs as
well as in humans (Buchanan et al. 1997)]
and more recently with the major milk aller-
gen β-lactoglobulin (del Val et al. 1999).
Further research with β-lactoglobulin revealed
that, in addition to decreasing the skin-test
challenge response in animals previously sen-
sitized to the native protein, thioredoxin
treatment alleviated the clinical symptoms
manifested by the dog (vomiting and diarrhea
or constipation). Recently, it has been shown
that the thioredoxin-reduced (disarmed) form
of β-lactoglobulin can be stabilized by either
reoxidation or derivatization with a physio-
logic disulfide compound (cystamine or
oxidized glutathione) (Morigasaki et al.
2001, 2003).
Dogs that were originally sensitized to
CM, beef, wheat, and soy proteins were
shown to produce speciﬁc IgE antibodies and
to respond to oral challenges with clinical
manifestations similar to those provoked in
humans. Additional animals have been sensi-
tized to peanut, walnut, or Brazil nut extracts
to determine whether sensitization with these
preparations is also accompanied by clinical
reactions, and whether cross-reactivity occurs
between the different preparations (Teuber
et al. 2002). At 6 months of age, these dogs
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tions to these extracts. IgE immunoblotting
of sera to peanut, walnut, and Brazil nut
showed strong recognition of proteins in the
aqueous preparations. At 2 years of age, each
of the peanut-sensitized and most of the
Brazil nut- and walnut-sensitized dogs reacted
on oral challenge with the corresponding pri-
mary immunogen. Little or no cross-reactivity
occurred among the different preparations
measured, either by skin tests or oral food
challenges, similar to that in the human clini-
cal picture. Furthermore, on the basis of skin
tests and oral challenges, the hierarchy of nut
and cereal allergen reactivity was also similar
to that seen with humans (peanuts > tree nuts
> soy > wheat > barley).
The similarity of the immune response to
that observed in humans raises the possibility
that the dog could be used to study food
allergy and that this model could potentially
be used to assess the allergenicity of proteins,
including those to which human populations
have not been exposed. In addition to being
used to assess the allergenicity of the native
form of proteins, the dog could in theory pre-
dict whether either the introduced protein of
interest or an unsuspected host component
had become an allergen as a result of the
transformation process. 
To address this question, pups from three
litters were sensitized at birth to a transgenic
corn leaf preparation containing a protein of
interest that on the basis of digestibility and
amino acid sequence analyses was unlikely an
allergen. These same pups were sensitized
simultaneously to several known allergens
(peanut, soy, milk, ragweed extracts). The
results obtained over a 2-year period demon-
strated that although the known allergens
elicited skin-test responses, the protein of
interest showed negligible activity. The results
support the conclusions that the protein of
interest is not an allergen, that the protein had
not become an allergen in the transformed
leaf, and that unidentiﬁed components of the
host also had not become allergenic.
Results obtained during the past decade
support the use of high IgE–producing dogs as
a potential model to assess and predict the
importance of proteins as human food aller-
gens. The proﬁle of allergenic foods, response
to individual allergens, and clinical reactions of
dogs are all similar to those observed in
humans. Furthermore, the ranking of the
potency of major food allergens is comparable.
The dog has additional advantages as an animal
model. Its large size permits the performance of
gastrointestinal studies such as sampling of
mucosa under endoscopy without sacrificing
the animal. In addition, as animals can be chal-
lenged repeatedly, individuals can be alternately
fed comparative diets such as control versus
thioredoxin-treated milk preparations.
The dog is, however, not without
limitations. Dogs are expensive to maintain,
and their immune response (with respect to
cytokines and chemokines, for example) is
not as well characterized as in models such as
the mouse or rat. Furthermore, sensitization is
a lengthy process, often requiring up to 18
months of repeated immunization in the pres-
ence of adjuvant to achieve a stable response.
In view of its promise, the dog warrants
further study as a model to assess and predict
potential food allergens. Like other animal
models currently being studied (mouse, rat,
pig), the dog may offer speciﬁc advantages for
investigation of this increasingly important
problem.
Allergenicity in Dogs II:
Spontaneous Food
Hypersensitivity/Allergy 
in a Colony of Dogs
Models used to identify and rank isolated
proteins for the potential to induce IgE anti-
body are highly sensitive for allergenic pro-
teins; however, they may have low speciﬁcity
for these proteins as dietary components, and
these models may not have the power to iden-
tify allergens in whole foods. Ideally, to detect
foods that are truly allergenic, a model should
provide for sensitization by the oral route
without adjuvants and demonstrate a clinical
response characteristic of atopic disease. Such
a model should also manifest IgE responses. It
has been suggested that such a model exists in
the spontaneously food-allergic dog.
Spontaneous allergic disease in dogs was
ﬁrst reported by Wittich (1941). This report
described seasonal rhinitis and conjunctivitis
analogous to human hay fever. Later, rhinitis,
conjunctivitis, and asthmatic signs were
demonstrated after exposing a seasonally spon-
taneous allergic dog to aerosolized ragweed
pollens (Patterson 1960). Although these ini-
tial reports in the literature focused on hay
fever–like symptoms in dogs, the more com-
mon manifestation observed by veterinarians
in practice is that of allergic dermatitis, and
this was first characterized in detail by
Halliwell (1971). From these early observa-
tions it was clear that the dog’s ability to man-
ifest allergic disease signs similar to humans
provided a useful model. Thus, reports have
appeared concerning induced allergic disease
in dogs ( Butler et al. 1983; Gold et al. 1972;
Patterson et al. 1974; Peters et al. 1982), and
most recently, the induced allergic dog model
has been applied to oral sensitization to food
proteins (Ermel et al. 1997).
Evidence from more than 30 years of
clinical observations shows that spontaneous
hypersensitivity to food by dogs is associated
with atopic dermatitis (Chamberlain 1978;
Criep 1968; Reedy et al. 1997; White 1986).
Spontaneous food hypersensitivity manifested
as dermatitis and enteric signs associated with
elevated food allergen–speciﬁc IgE has recently
been described in the founding stock of a
colony of Maltese × beagle dogs. About half of
the offspring in this colony manifest clinical
signs of atopic disease before 6 months of age
when fed standard chow. Additional studies of
offspring from this founding stock, reported
below, demonstrate the ability of these dogs to
be sensitized to allergens present in food, and
to respond with clinical signs of atopic disease
to food allergens in amounts comparable with
those reported to elicit disease in humans.
Furthermore, clinical disease is associated with
elevated levels of food allergen–specific IgE
(Jackson and Hammerberg 2002).
Twelve Maltese × beagle dogs 1–3 years of
age, born and reared indoors without exposure
to helminth or arthropod parasites, demon-
strated clinical signs of nonseasonal atopic der-
matitis when fed standard dog chow
containing corn, wheat, and soy proteins,
among other ingredients (Jackson et al. In
press). The dogs were given monthly tablets
containing soy and pork for flavoring. The
amount of soy and pork protein contained in
each tablet provided about 1–2 mg/kg body
weight for each dog. Two months before the
start of the trial, the diet was changed to a
hypoallergenic food consisting of cooked rice
and duck, which allowed resolution of clinical
signs of atopic dermatitis. On day 0, prior to
receiving the flavored tablet, and at regular
intervals for 45 days, dogs were bled and
scored for pruritus, erythema and excoriation,
and evidence of secondary skin/otic infections.
These measurements were combined for a total
clinical score.
Clinical scores for pruritus showed marked
increases at 8–13 days after ingestion of the
ﬂavored tablet. Speciﬁc IgE antibodies for soy
showed statistically signiﬁcant increases from
day 0 levels at day 5 (p = 0.001), day 8
(p = 0.03), and day 20 (p = 0.03). Antibodies
for pork tended to be elevated on day 5, but
only on day 20 was there a statistically signiﬁ-
cant increase (p = 0.03). Even though corn
was not part of the tablet composition, signiﬁ-
cant increases occurred in anti–corn IgE at the
three time points sampled from days 20 to 45.
No signiﬁcant increase was observed in total
serum IgE, indicating there was no major
polyclonal stimulation of IgE production by
the ingestion of this amount of allergen. Thus,
the elevated levels of allergen-speciﬁc IgE were
not due to a nonspecific increase in total
serum IgE. Indeed, there was a statistically
signiﬁcant decrease in total serum IgE at day 5.
These results demonstrate that develop-
ment of clinically signiﬁcant pruritic skin dis-
ease and otitis occurring in Maltese × beagle
dogs 2–5 days after being fed small amounts
of selected food proteins is associated with
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food proteins. A second peak of allergen-spe-
ciﬁc IgE at about 20 days was also observed.
This dynamic response in speciﬁc IgE associ-
ated with food allergen challenge during
maintenance on a hypoallergenic diet can be
exploited to identify naturally sensitizing and
eliciting allergen epitopes on food allergens.
Peanut Allergy in a Swine
Model
Experimentally induced allergic disease in
large animals that closely mimics allergic dis-
eases in humans can be a useful model.
Investigations in swine and calves demon-
strate the induction of hypersensitivity
responses that are similar to those of human
allergic disease (Barratt et al. 1978). Young
piglets have been used as models for sensitiza-
tion/tolerance to CM and soy proteins, with
responses that parallel those seen in young
children (Bailey et al. 1993; Hankins et al.
1992; Heppell et al. 1989; Li et al. 1991;
Rees et al. 1989; Wilson et al. 1989). It is fre-
quently assumed that similarities exist
between swine and humans with respect to
skin and gastrointestinal tract anatomy and
physiology as well as immunology. The devel-
opment and characterization of the swine as a
model for the allergen-sensitizing capacity of
novel proteins will be a valuable tool for
investigations into the immunopathologic
mechanisms of gastrointestinal allergy. 
Although anti–swine IgE is not available
commercially, IgE-like responses in swine
include Ascaris suum airways sensitization and
challenge that lead to eosinophil infiltration
and a late-phase asthmatic reaction (Alving et
al. 1991; Fornhem et al. 1996). Immediate
skin-test responses with heat-inactivated
serum to antigenic soybean products and
Ascaris suum extracts have also been described
(Barriga and Ingalls 1984; Dreau et al. 1994).
Moreover, gastrointestinal-associated adverse
immunologic reactions include emesis, diar-
rhea, bleeding, and weight loss, which are also
associated with human gastrointestinal allergy. 
Because the newborn piglet mimics many
of the features of the human newborn, par-
ticularly with respect to digestive and
immunologic function, a neonatal swine
food allergy model has been developed using
peanut as the sensitizing agent. Preliminary
experimental designs included intragastric
and intraperitoneal sensitizations in the pres-
ence or absence of cholera toxin as an adju-
vant at different times with oral challenges 2
weeks after the last sensitization. Animals
were taken off food and water 18 hr prior to
oral challenge. An optimal sensitization regi-
men consisted of a dose of 500 µg/mL
peanut extract administered by intraperi-
toneal injection in the presence of 100 µg
cholera toxin on days 7, 8, and 9, followed
by two additional boosts on days 17 and 25.
Using this sensitization regime, greater than
75% of peanut-sensitized piglets responded
with clinical symptoms of emesis, extreme
lethargy/malaise, tremors, convulsions, and
major areas of edematous rashes. The allergic
response was determined by repeated intra-
gastric challenge with 10 g peanut meal and
skin testing with peanut extracts (whole
peanut extract, Ara h1 and 2) performed on
alternating weeks beginning at week 5 and
ending at week 12.
Physical, histologic, and immunologic
assessments were made after oral challenges,
skin testing, or tissue analysis. Control ani-
mals receiving either phosphate-buffered
saline (PBS) or PBS with cholera toxin did
not show signs, symptoms, or immunologic
or histologic evidence of gastrointestinal
allergy. Additionally, peanut-sensitized ani-
mals challenged with soybean/peanut-free diet
did not respond with allergic symptoms, sug-
gesting a peanut-specific response. The fol-
lowing physical observations were evident in
only peanut-sensitized piglets. Whole-body
rashes, including maculopapular rashes,
lethargy, and difficulty in breathing as evi-
denced by stridor, were present within 2 hr of
oral challenge. Gastrointestinal signs included
contractions and emesis within 2 hr of oral
challenge and diarrhea within 18 hr. Labored
breathing was in evidence and required
treatment in two animals.
Immunologic assessment revealed a 2- to
3-fold increase in peripheral blood mononu-
clear cell (PBMC) proliferation to whole-
peanut extract and peanut allergens Ara h1
and 2 compared with PBMC proliferation to
medium alone or rice as a control allergen
protein. Peanut-specific IgG increased from
baseline levels at day 7 (0.1–0.5 µg/mL) to
greater than 100 µg/mL by day 40 and per-
sisted to day 90. Immediate skin-test
responses as evidenced by wheal and flare
reactions suggested an IgE-mediated hyper-
sensitivity response. In PCA experiments,
serum from peanut skin-test–positive and oral
challenge–positive animals administered
intradermally into naïve animals responded
with positive skin test to an intravenous chal-
lenge of peanut extract 24 hr after intradermal
skin sensitization. Heat treatment at 56°C for
1 hr ablated the skin-sensitizing ability, fur-
ther suggesting an IgE-mediated mechanism.
Animals responding within 2 hr to an oral
challenge by emesis were sacriﬁced for physical
and histological assessment of gastrointestinal
tract tissues. Dissection of the stomach of these
animals revealed minor quantities of peanut
meal compared with abundant amounts of
peanut meal in the stomachs of nonsensitized
or soybean-/peanut-free diet–challenged ani-
mals. A summary of histologic data from 6
controls and 17 peanut positive–challenged
animals revealed the following information.
The most prominent findings were vascular
congestion and hemorrhage that occurred pri-
marily in the proximal intestine. Similar fea-
tures appeared in other parts of the intestinal
tract but did not appear as severe and were
probably associated with the early sacriﬁce of
the animals and failure of food to reach the
intestinal extremities. Additional markers of a
gastrointestinal allergic response included
mucus extrusion and submucosal edema.
Speciﬁcally, the esophagus was routinely nor-
mal. The stomach showed normal architecture
(10 pigs) focal eosinophilia and submucosal
edema (2 pigs), and large amounts of mucus
extrusion into the lumen (5 pigs), with vascular
congestion and hemorrhage in 2 pigs. In the
small intestine the following were observed:
focal eosinophilia with large numbers in 2 pigs,
submucosal edema (10 pigs), mucus extrusion
(2 pigs), epithelial denudation (3 pigs), focal
villous shortening (2 pigs), and vascular con-
gestion (14 pigs) with hemorrhage in 3 pigs.
The proximal small intestine appeared to be
more affected than the distal region. Evidence
of food in this region was also limited, suggest-
ing that the early sacriﬁce may contribute to
the limited ﬁnding in the distal regions of the
small intestine. The colon was normal in 11
pigs, with occasional vascular congestion in 4
pigs; 2 pigs demonstrated crypt abscesses.
In conclusion, the neonatal swine model
is an appropriate peanut food-allergy model
that can be used to determine the relative
physical signs of human allergy including
emesis, erythematous rashes, and skin testing.
Tissue abnormalities appear to be similar to
other endoscopically obtained tissues from
allergen-sensitized/challenged animals.
Conclusion
Considerable progress has been made in
developing animal models for the assessment
of the allergenic potential of novel proteins.
However, it is important to acknowledge that
none of these has yet been evaluated rigor-
ously or validated formally. Much still has to
be achieved, but with a continued investment
in relevant research, it should prove possible
to contribute to the safety assessment process
by providing one or more methods based on
responses in animals.
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